ENTVANTAGE DIAGNOSTICS, INC

Austin, TX · Founded 2014 · Medtech · Private

Point-of-care diagnostic test kit for identifying bacterial pathogens in sinusitis, including a specialized mucus collection device and multiplexed assay with reader system

Claim this profile

Follows are private to you and power your alerts

Updated · entvantagedx.com

Sector
Medtech
Headquarters
Austin, TX
Founded
2014
Latest Form D
$515K, Sep 2019
Total capital
$8M
Federal grants
$1.7M
1 award · 2021
Rank in peer group#140 of 477
Private capital raised
$6.3M
4 Form D · last Sep 2019
86 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
4
3 pending · first 2017
Rank in peer group#79 of 477

Capital timeline

2015201620172018201920202021FEDERAL ↑EQUITY ↓Cumulative $8M$1.7M1st Form D$1M2nd Form D$1.4M3rd Form D$3.3M4th Form D$515K
2015201720192021FEDERAL ↑EQUITY ↓Cumulative $8M$1.7M

Latest events

  • Federal grantHealth and Human S · Phase II · Clinical Validation of Sinu-Test, A Multiplexed Device for Rapid Diagnosis of Acute Bacterial Sinusitis, to support CLIA Waiver$1.7M
  • Private capital raisedForm D · SEC · 4th filing$515K
  • Private capital raisedForm D · SEC · 3rd filing$3.3M
  • Private capital raisedForm D · SEC · 2nd filing$1.4M
  • Private capital raisedForm D · SEC · 1st filing$1M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 477 peers

Line = median

Medtech · Device

  • Federal grants#140 · top 29%
  • Granted patents#79 · top 17%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Joseph S SkrabaResearcherExecutive Officer, DirectorLinked by 3 patents
  • Blobel S FriedhelmDirectorNamed in SEC Form D filings
  • Donald GonzalesDirectorNamed in SEC Form D filings
  • John S PaulosDirectorNamed in SEC Form D filings
  • Richard J HawkinsDirectorNamed in SEC Form D filings
  • Russell S BradleyDirectorNamed in SEC Form D filings

What it has protected

USPTO · 4 granted of 7
Show all 7 patent records

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .